Interleukin-10 Inhibits Lipopolysaccharide Induced miR-155 Precursor Stability and Maturation

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Cheung, Sylvia T ^a,b   So, Eva Y ^a,b   Chang, David ^a,b   Ming Lum, Andrew ^a,b   Mui, Alice L F ^a,b  

^a VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MICRORNA 155; PHOSPHATASE; PROTEIN SHIP1; RNA PRECURSOR; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; NONHUMAN; NUCLEAR EXPORT SIGNAL; PROTEIN PROCESSING; PROTEIN RNA BINDING; RAT; RNA STABILITY; RNA TRANSCRIPTION;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CELL NUCLEUS; FEMALE; GENE EXPRESSION REGULATION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICRORNAS; PHOSPHORIC MONOESTER HYDROLASES; RNA PRECURSORS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA STABILITY; STAT3 TRANSCRIPTION FACTOR;

EID: 84881536351     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071336     Document Type: Article

References (61)

1. Lu Y-C, Yeh W-C, Ohashi PS, (2008) LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151.
2. Papadimitraki ED, Bertsias GK, Boumpas DT, (2007) Toll like receptors and autoimmunity: A critical appraisal. Journal of Autoimmunity 29: 310-318.
3. Karin M, Lawrence T, Nizet V, (2006) Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer. Cell 124: 823-835.
4. Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, et al. (2001) Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J 20: 3760-3770.
5. Rennick DM, Fort MM, Davidson NJ, (1997) Studies with IL-10-/- mice: an overview. Journal of Leukocyte Biology 61: 389-396.
6. Murray PJ, (2005) The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proceedings of the National Academy of Sciences of the United States of America 102: 8686-8691.
7. Kennedy RJ, Hoper M, Deodhar K, Erwin PJ, Kirk SJ, et al. (2000) Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease. British Journal of Surgery 87: 1346-1351.
8. Asadullah K, Eskdale J, Wiese A, Gallagher G, Friedrich M, et al. (2001) Interleukin-10 Promoter Polymorphism in Psoriasis. 116: 975-978.
9. Glocker E-O, Kotlarz D, Boztug K, Gertz EM, Schäffer AA, et al. (2009) Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor. New England Journal of Medicine 361: 2033-2045.
10. Louis E, Libioulle C, Reenaers C, Belaiche J, Georges M, (2009) Genetics of ulcerative colitis: the come-back of interleukin 10. Gut 58: 1173-1176.
11. O'Garra A, Murphy KM, (2009) From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce TH1 development. Nat Immunol 10: 929-932.
12. Williams L, Bradley L, Smith A, Foxwell B, (2004) Signal Transducer and Activator of Transcription 3 Is the Dominant Mediator of the Anti-Inflammatory Effects of IL-10 in Human Macrophages. The Journal of Immunology 172: 567-576.
13. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, et al. (1999) Enhanced Th1 Activity and Development of Chronic Enterocolitis in Mice Devoid of Stat3 in Macrophages and Neutrophils. Immunity 10: 39-49.
14. Lang R, Patel D, Morris JJ, Rutschman RL, Murray PJ, (2002) Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-10. The Journal of Immunology 169: 2253-2263.
15. Chan CS, Ming-Lum A, Golds GB, Lee SJ, Anderson RJ, et al. (2012) Interleukin-10 inhibits LPS induced TNFα translation through a SHIP1-dependent pathway. Journal of Biological Chemistry.
16. Huber M, Helgason CD, Damen JE, Liu L, Humphries RK, et al. (1998) The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proceedings of the National Academy of Sciences 95: 11330-11335.
17. Krystal G, (2000) Lipid phosphatases in the immune system. Seminars in Immunology 12: 397-403.
18. Burgering BMT, Coffer PJ, (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-602.
19. Lee Y, Kim M, Han J, Yeom K-H, Lee S, et al. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23: 4051-4060.
20. Lee Y, Ahn C, Han J, Choi H, Kim J, et al. (2003) The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
21. Yi R, Qin Y, Macara IG, Cullen BR, (2003) Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes & Development 17: 3011-3016.
22. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R, (2006) Control of translation and mRNA degradation by miRNAs and siRNAs. Genes & Development 20: 515-524.
23. Gantier MP, (2010) New Perspectives in MicroRNA Regulation of Innate Immunity Journal of Interferon & Cytokine Research. 30: 283-289.
24. Ruggiero T, Trabucchi M, De Santa F, Zupo S, Harfe BD, et al. (2009) LPS induces KH-type splicing regulatory protein-dependent processing of microRNA-155 precursors in macrophages. The FASEB Journal 23: 2898-2908.
25. Tili E, Michaille J-J, Cimino A, Costinean S, Dumitru CD, et al. (2007) Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNFα Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock. The Journal of Immunology 179: 5082-5089.
26. Tam W, (2001) Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 274: 157-167.
27. Eis PS, Tam W, Sun L, Chadburn A, Li Z, et al. (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proceedings of the National Academy of Sciences of the United States of America 102: 3627-3632.
28. Tam W, Dahlberg JE, (2006) miR-155/BIC as an oncogenic microRNA. Genes, Chromosomes and Cancer 45: 211-212.
29. Calame K, (2007) MicroRNA-155 Function in B Cells. Immunity 27: 825-827.
30. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, et al. (2007) Requirement of bic/microRNA-155 for Normal Immune Function. Science 316: 608-611.
31. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D, (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proceedings of the National Academy of Sciences 104: 1604-1609.
32. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D, (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proceedings of the National Academy of Sciences 106: 7113-7118.
33. Cremer TJ, Ravneberg DH, Clay CD, Piper-Hunter MG, Marsh CB, et al. (2009) MiR-155 Induction by F. novicida but Not the Virulent F. tularensis Results in SHIP Down-Regulation and Enhanced Pro-Inflammatory Cytokine Response. PLoS ONE 4: e8508.
34. Wang X, Zhao Q, Matta R, Meng X, Liu X, et al. (2009) Inducible Nitric-oxide Synthase Expression Is Regulated by Mitogen-activated Protein Kinase Phosphatase-1. Journal of Biological Chemistry 284: 27123-27134.
35. Bala S, Marcos M, Kodys K, Csak T, Catalano D, et al. (2011) Up-regulation of MicroRNA-155 in Macrophages Contributes to Increased Tumor Necrosis Factor α (TNFα) Production via Increased mRNA Half-life in Alcoholic Liver Disease. Journal of Biological Chemistry 286: 1436-1444.
36. Stamou P, Kontoyiannis DL, (2010) Posttranscriptional regulation of TNF mRNA: a paradigm of signal-dependent mRNA utilization and its relevance to pathology. Curr Dir Autoimmun 11: 61-79.
37. McCoy CE, Sheedy FJ, Qualls JE, Doyle SL, Quinn SR, et al. (2010) IL-10 Inhibits miR-155 Induction by Toll-like Receptors. Journal of Biological Chemistry 285: 20492-20498.
38. Watanabe S, Mui AL, Muto A, Chen JX, Hayashida K, et al. (1993) Reconstituted human granulocyte-macrophage colony-stimulating factor receptor transduces growth-promoting signals in mouse NIH 3T3 cells: comparison with signalling in BA/F3 pro-B cells. Molecular and Cellular Biology 13: 1440-1448.
39. Crellin NK, Garcia RV, Levings MK, (2007) Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells. Blood 109: 2014-2022.
40. Kohn AD, Barthel A, Kovacina KS, Boge A, Wallach B, et al. (1998) Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem 273: 11937-11943.
41. Kim VN, (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385.
42. Yin Q, Wang X, McBride J, Fewell C, Flemington E, (2008) B-cell Receptor Activation Induces BIC/miR-155 Expression through a Conserved AP-1 Element. Journal of Biological Chemistry 283: 2654-2662.
43. Hargreaves DC, Horng T, Medzhitov R, (2009) Control of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation. Cell 138: 129-145.
44. Ong CJ, Ming-Lum A, Nodwell M, Ghanipour A, Yang L, et al. (2007) Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood 110: 1942-1949.
45. Hamilton MJ, Ho VW, Kuroda E, Ruschmann J, Antignano F, et al. (2011) Role of SHIP in cancer. Experimental Hematology 39: 2-13.
46. Mirza AM, Kohn AD, Roth RA, McMahon M, (2000) Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB. Cell Growth Differ 11: 279-292.
47. Cross DAE, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA, (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378: 785-789.
48. Song H, Wang R, Wang S, Lin J, (2005) A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 102: 4700-4705.
49. Lu L-F, Liston A, (2009) MicroRNA in the immune system, microRNA as an immune system. Immunology 127: 291-298.
50. O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, et al. (2008) Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. The Journal of Experimental Medicine 205: 585-594.
51. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z, et al. (2007) microRNA-155 Regulates the Generation of Immunoglobulin Class-Switched Plasma Cells. Immunity 27: 847-859.
52. Ceppi M, Pereira PM, Dunand-Sauthier I, Barras E, Reith W, et al. (2009) MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cells. Proceedings of the National Academy of Sciences 106: 2735-2740.
53. Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, et al. (2011) MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proceedings of the National Academy of Sciences 108: 11193-11198.
54. Faraoni I, Antonetti FR, Cardone J, Bonmassar E, (2009) miR-155 gene: A typical multifunctional microRNA. Biochimica et Biophysica Acta (BBA)- Molecular Basis of Disease 1792: 497-505.
55. Davis BN, Hilyard AC, Lagna G, Hata A, (2008) SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61.
56. Yamagata K, Fujiyama S, Ito S, Ueda T, Murata T, et al. (2009) Maturation of MicroRNA Is Hormonally Regulated by a Nuclear Receptor. Molecular Cell 36: 340-347.
57. Pilotte J, Dupont-Versteegden EE, Vanderklish PW, (2011) Widespread Regulation of miRNA Biogenesis at the Dicer Step by the Cold-Inducible RNA-Binding Protein, RBM3. PLoS ONE 6: e28446.
58. Briata P, Lin WJ, Giovarelli M, Pasero M, Chou CF, et al. (2012) PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis. Cell Death Differ 19: 478-487.
59. Finbloom DS, Winestock KD, (1995) IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. The Journal of Immunology 155: 1079-1090.
60. Murray PJ, (2006) STAT3-mediated anti-inflammatory signalling. Biochem Soc Trans 34: 1028-1031.
61. Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, et al. (2009) The Kinase Akt1 Controls Macrophage Response to Lipopolysaccharide by Regulating MicroRNAs. Immunity 31: 220-231.